Please login to the form below

Is fear an effective driver of behaviour change?

Client Lead Natalie Seebeck explains that applying fear-based models in communications can be effective, if the right components are used in the right way.
Since the mid-1950s, fear appeals have been applied in an effort to reduce a number of risky, yet modifiable, health related behaviours.¹ Today, they still remain a popular technique for creative agencies, researchers, interventionists, and policy makers.² Even influential bodies such as the World Health Organisation argue in favour of one of the best-illustrated examples of fear appeals; the health warnings on cigarette packages.³ However, if you ask a smoker about the warnings, you’ll often hear “I just ignore the warnings”, or “that’s not me so why would it affect me”.

So, can fear really motivate someone to change their behavior? Can it make a healthcare professional (HCP) choose one treatment over the other? Can it make a patient more adherent to their treatment or encourage them to exercise more, or change their diet? Can it make an HCP prescribe a treatment sooner rather than later?

Despite caution from some researchers, Client Lead Natalie Seebeck explains that applying fear-based models, specifically Protection Motivation Theory (PMT) and the Extended Parallel Processing Model (EPPM), in communications can be effective, if the right components are used in the right way. 

What is a ‘fear appeal’, and how does it work?

According to widely adopted fear appeal theories, such as PMT and EPPM, fear appeals are persuasive communications that consist of two key components:
  1. the presentation of a threat to an individual’s well-being that induces fear
  2. the presentation of recommendations, such as steps to avoid the threat or reduce the impact of the threat.⁴
Once these are presented, an individual’s evaluation or appraisal of these components is expected to result in a motivation to change behaviour.

Protection Motivation Theory: Weighing the threat against the cost of prevention

PMT, or Protection Motivation Theory, says that a change response is the result of two integrated appraisal processes: firstly a threat appraisal, followed by a coping appraisal.⁵
  1. A threat appraisal is the process whereby an individual compares the perceived severity of a threat and their personal likelihood of the worst case outcome, against the potential rewards of engaging in the risky behaviour.
  2. A coping appraisal is the process whereby an individual compares the efficacy of the recommended “self-protective” behaviour and the ease and confidence of executing that behavior, against the costs of choosing that risk reducing behaviour.⁵
The theory states that if the coping appraisal outweighs the threat appraisal, the individual will be motivated and implement the recommended “self-protective” behaviour.⁵For example:
  • Liz, who knows she has a high risk for skin cancer due to family history and skin type, will be more likely to apply sun cream (provided it is easy for them to access, and relatively cheap to purchase).
  • Leo, who knows he has a lower risk of skin cancer, or for whom the cost or convenience of applying sun cream is much higher, will probably forego it.
  1.  Floyd, Prentice-Dunn, and Rogers, 2000
  2.  Ruiter, Kessels, Peters, and Kok, 2014
  3.  Fong, Hammond, and Hitchman, 2009
  4.  Rogers, 1975; Witte, 1992
  5.  Rogers, 1975

Download the full article with PMT and EPPM models from Blue Latitude Health

1st February 2017



Company Details

Blue Latitude Health

+44 203 328 1840

Contact Website

Blue Latitude Health
Crusader House
145-157 St John Street
United Kingdom

Latest content on this profile

Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big data.
Blue Latitude Health
Lynch syndrome: a patient perspective
Blue Latitude Health intern Costantino Ciotti gives an insight into life with Lynch Syndrome, a genetic condition associated with colon cancer. Here he explores the patient’s perspective, including treatment options, and gives his advice for healthcare professionals diagnosing patients with a genetic disease.
Blue Latitude Health
What does programmatic advertising mean for your pharma marketing strategy?
Senior Associate Consultant Jiayi Chen explains the benefits and pitfalls of programmatic advertising and reveals how it can impact return on investment in your marketing campaigns.
Blue Latitude Health
How to measure marketing success: profit vs ROI
Measuring marketing activity is proving to be a major challenge in pharma. Here, Senior Consultant Paul Townley-Jones explores the meaning of success and gives his tips for measuring efficiency and effectiveness, along with the formula for calculating profit and ROI.
Blue Latitude Health
Perspective on biotech leaders
In the latest issue of Perspective magazine, seven industry trailblazers reveal the trends, challenges and opportunities they anticipate in the biotech sector, from empowering patients to deciphering big data.
Blue Latitude Health
Global customer research in healthcare: 10 tips for capturing insights that matter
What makes a strong brand? One global core coupled with sensitivity to regions and countries. In part two of our series on customer insight and behaviour change, we share our tips on optimising global customer research projects to ensure you get the balance right in an efficient way.
Blue Latitude Health